Literature DB >> 8791681

How tumors become angiogenic.

N Bouck1, V Stellmach, S C Hsu.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8791681     DOI： 10.1016/s0065-230x(08)60862-3

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN： 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  91 in total

1.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.

Authors:  G Bergers; R Brekken; G McMahon; T H Vu; T Itoh; K Tamaki; K Tanzawa; P Thorpe; S Itohara; Z Werb; D Hanahan
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

2.  Collateral expression of proangiogenic and tumorigenic properties in intestinal epithelial cell variants selected for resistance to anoikis.

Authors:  J Rak; Y Mitsuhashi; C Sheehan; J K Krestow; V A Florenes; J Filmus; R S Kerbel
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

Review 3.  Mathematical modeling of tumor-induced angiogenesis.

Authors:  Nikos V Mantzaris; Steve Webb; Hans G Othmer
Journal:  J Math Biol       Date:  2004-02-06       Impact factor: 2.259

4.  Vasohibin: the feedback on a new inhibitor of angiogenesis.

Authors:  Robert S Kerbel
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

5.  Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.

Authors:  O V Volpert; W F Ward; M W Lingen; L Chesler; D B Solt; M D Johnson; A Molteni; P J Polverini; N P Bouck
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

6.  Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions.

Authors:  N Chandrasekar; S Jasti; W K Alfred-Yung; F Ali-Osman; D H Dinh; W C Olivero; M Gujrati; A P Kyritsis; G L Nicolson; J S Rao; S Mohanam
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

7.  G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab.

Authors:  Ondrej Fiala; Tomas Buchler; Beatrice Mohelnikova-Duchonova; Bohuslav Melichar; Vit Martin Matejka; Lubos Holubec; Jana Kulhankova; Zbynek Bortlicek; Marie Bartouskova; Vaclav Liska; Ondrej Topolcan; Monika Sedivcova; Jindrich Finek
Journal:  Tumour Biol       Date:  2015-12-10

8.  An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface.

Authors:  Nick R Burwick; Miriam L Wahl; Jun Fang; Zhaoxi Zhong; Tammy L Moser; Bo Li; Roderick A Capaldi; Daniel J Kenan; Salvatore V Pizzo
Journal:  J Biol Chem       Date:  2004-11-04       Impact factor: 5.157

9.  Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

Authors:  I Struman; F Bentzien; H Lee; V Mainfroid; G D'Angelo; V Goffin; R I Weiner; J A Martial
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications.

Authors:  Rifat Hasina; Mark E Whipple; Leslie E Martin; Winston Patrick Kuo; Lucila Ohno-Machado; Mark W Lingen
Journal:  Lab Invest       Date:  2008-02-18       Impact factor: 5.662
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.